Anti-Inflammatory Activity of a Novel Family of Aryl Ureas Compounds in an Endotoxin-Induced Airway Epithelial Cell Injury Model

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Cabrera Benitez, Nuria E ^a,b   Pérez Roth, Eduardo ^c   Casula, Milena ^a,b   Ramos Nuez, Ángela ^a,b   Ríos Luci, Carla ^c   Rodríguez Gallego, Carlos ^b   Sologuren, Ithaisa ^b   Jakubkiene, Virginija ^d   Slutsky, Arthur S ^e,f   Padrón, José M ^c   Villar, Jesús ^a,b,e  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^c UNIVERSIDAD DE LA LAGUNA   (Spain)

^d VILNIUS UNIVERSITY   (Lithuania)

^e ST MICHAEL'S HOSPITAL   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CKT 0103; EMODIN; I KAPPA B ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; RHEIN; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; UREA DERIVATIVE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DAMAGE; CELL STRUCTURE; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; DRUG EFFECT; DRUG POTENCY; DRUG STRUCTURE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; LONG TERM EXPOSURE; LUNG ALVEOLUS EPITHELIUM; PROTEIN EXPRESSION; UPREGULATION;

ANTI-INFLAMMATORY AGENTS; CELL LINE; CELL SHAPE; CELL SURVIVAL; CYTOKINES; ENDOTOXINS; EPITHELIAL CELLS; HUMANS; I-KAPPA B PROTEINS; IMMUNOBLOTTING; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; LUNG; MODELS, BIOLOGICAL; TOLL-LIKE RECEPTOR 4; UREA;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 84869020324     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048468     Document Type: Article

References (55)

1. Ware LB, Matthay MA, (2000) The acute respiratory distress syndrome. N Engl J Med 342: 1334-1349.
2. Brun-Buisson C, Minelli C, Bertolini G, Brazzi L, Pimentel J, et al. (2004) Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study. Intensive Care Med 30: 51-61.
3. Vincent JL, Sun Q, Dubois MJ, (2002) Clinical trials of immunomodulatory therapies in severe sepsis and septic shock. Clin Infect Dis 34: 1084-1093.
4. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, et al. (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29: 1303-1310.
5. Sparwasser T, Miethke T, Lipford G, Borschert K, Hacker H, et al. (1997) Bacterial DNA causes septic shock. Nature 386: 336-337.
6. Fan J, Ye RD, Malik AB, (2001) Transcriptional mechanisms of acute lung injury. Am J Physiol Lung Cell Mol Physiol 281: L1037-1050.
7. Lin WJ, Yeh WC, (2005) Implication of Toll-like receptor and tumor necrosis factor alpha signaling in septic shock. Shock 24: 206-209.
8. Ma SF, Grigoryev DN, Taylor AD, Nonas S, Sammani S, et al. (2005) Bioinformatic identification of novel early stress response genes in rodent models of lung injury. Am J Physiol Lung Cell Mol Physiol 289: L468-L477.
9. Zeiher BG, Artigas A, Vincent JL, Dmitrienko A, Jackson K, et al. (2004) Neutrophil elastase inhibition in acute lung injury: results of the STRIVE study. Critical Care Med 32: 1695-1702.
10. Matthay MA, Brower RG, Carson S, Douglas IS, Eisner M, et al. (2011) Randomized, placebo-controlled clinical trial of an aerosolized beta-agonist for treatment of acute lung injury. Am J Respir Crit Care Med 184: 561-568.
11. Shoemaker RH, (2006) The NCI60 human tumour cell line anticancer drug screen. Nat Rev Cancer 6: 813-823.
12. Leon LG, Rios-Luci C, Tejedor D, Perez-Roth E, Montero JC, et al. (2010) Mitotic arrest induced by a novel family of DNA topoisomerase II inhibitors. J Med Chem 53: 3835-3839.
13. Leon LG, Carballo RM, Vega-Hernandez MC, Miranda PO, Martin VS, et al. (2008) Beta-hydroxy-alpha,beta-unsaturated ketones: A new pharmacophore for the design of anticancer drugs. Part 2. ChemMedChem 3: 1740-1747.
14. Koyama S, Sato E, Nomura H, Kubo K, Miura M, et al. (1999) The potential of various lipopolysaccharides to release monocyte chemotactic activity from lung epithelial cells and fibroblasts. Eur Respir J 14: 545-552.
15. MacRedmond R, Singhera GK, Dorscheid DR, (2009) Erythropoietin inhibits respiratory epithelial cell apoptosis in a model of acute lung injury. Eur Respir J 33: 1403-1414.
16. Liaudet L, Mabley JG, Pacher P, Virág L, Soriano FG, et al. (2002) Inosine exerts a broad range of antiinflammatory effects in a murine model of acute lung injury. Ann Surg 235: 568-578.
17. Yeh CH, Cho W, So EC, Chu CC, Lin MC, et al. (2011) Propofol inhibits lipopolysaccharide-induced lung epithelial cell injury by reducing hypoxia-inducible factor-1alpha. Br J Anaesth 106: 590-599.
18. Wang YL, Malik AB, Sun Y, Hu S, Reynolds AB, et al. (2011) Innate immune function of a dherens junction protein p120-catenin in endothelial response to endotoxin. J Immunol 186: 3180-3187.
19. Muroya M, Chang K, Uchida K, Bougaki M, Yamada Y, (2012) Analysis of cytotoxicity induced by proinflammatory cytokines in the human alveolar epithelial cell line A549. Biosci Trends 6: 70-80.
20. Boots AW, Gerloff K, Bartholomé R, van Berlo D, Ledermann K, et al. (2012) Neutrophils augment LPS-mediated pro-inflammatory signaling in human lung epithelial cells. Biochim Biophys Acta 1823: 1151-1162.
21. Jakubkiene VKZ, Barbuliene MM, Vainilavicius P, (2010) Synthesis of (pyrimidin4-yloxy)-and (pyrimidin-3-yl)acetyl azides and their rearrangement to carbamates and ureas. Arkivoc 11: 39-48.
22. Liu X, Cheng J, Zheng X, Chen Y, Wu C, et al. (2009) Targeting CpG DNA to screen and isolate anti-sepsis fraction and monomers from traditional Chinese herbs using affinity biosensor technology. Int Immunopharmacol 9: 1021-1031.
23. Larsson BM, Larsson K, Malmberg P, Palmberg L, (1999) Gram positive bacteria induce IL-6 and IL-8 production in human alveolar macrophages and epithelial cells. Inflammation 23: 217-230.
24. Strober W, (2001) Trypan blue exclusion test of cell viability. Curr Protoc Immunol Appendix 3: Appendix 3B.
25. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, et al. (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82: 1107-1112.
26. Shoemaker RH, Scudiero DA, Melillo G, Currens MJ, Monks AP, et al. (2002) Application of high-throughput, molecular-targeted screening to anticancer drug discovery. Curr Top Med Chem 2: 229-246.
27. Charles PE, Tissières P, Barbar SD, Croisier D, Dufour J, et al. (2011) Mild-stretch mechanical ventilation upregulates toll-like receptor 2 and sensitizes the lung to bacterial lipopeptide. Crit Care 15: R181.
28. Bachofen M, Weibel ER, (1997) Alterations of the gas exchange apparatus in adult respiratory insufficiency associated with septicemia. Am Rev Respir Dis 116: 589-615.
29. Strieter RM, Belperio JA, Keane MP, (2002) Cytokines in innate host defense in the lung. J Clin Invest 109: 699-705.
30. Cheng DS, Han W, Chen SM, Sherrill TP, Chont M, et al. (2007) Airway epithelium controls lung inflammation and injury through the NF-kappa B pathway. J Immunol 178: 6504-6513.
31. Mittal N, Sanyal SN, (2011) In vivo effect of surfactant on inflammatory cytokines during endotoxin-induced lung injury in rodents. J Immunotoxicol 8: 274-283.
32. Fortis S, Speith PM, Lu WY, Parotto M, Haitsma JJ, et al. (2012) Effects of anesthetic regimes on inflammatory responses in a rat model of acute lung injury. Intensive Care Med 38: 1548-1555.
33. Tang PS, Mura M, Seth R, Liu M, (2008) Acute lung injury and cell death: how many ways can cells die? Am J Physiol Lung Cell Mol Physiol 294: L632-L641.
34. Magalhães CB, Riva DR, DePaula LJ, Brando-Lima A, Koatz VL, et al. (2010) In vivo anti-inflammatory action of eugenol on lipopolysaccharide-induced lung injury. J Appl Physiol 108: 845-851.
35. Martin G, Bogdanowicz P, Domagala F, Ficheux H, Pujol JP, (2003) Rhein inhibits interleukin-1 beta-induced activation of MEK/ERK pathway and DNA binding of NK-kappa B and AP-1 in chondrocytes cultured in hypoxia: a potential mechanism for its disease-modifying effect in osteoarthitis. Inflammation 27: 233-246.
36. Li HL, Chen HL, Li H, Zhang KL, Chen XY, et al. (2005) Regulatory effects of emodin on NF-kappaB activation and inflammatory cytokine expression in RAW 264.7 macrophages. Int J Mol Med 16: 41-47.
37. Riedemann NC, Guo RF, Ward PA, (2003) The enigma of sepsis. J Clin Invest 112: 460-467.
38. Li X, Su J, Cui X, Li Y, Barochia A, et al. (2009) Can we predict the effects of NF-kappaB inhibition in sepsis? Studies with parthenolide and ethyl pyruvate. Expert Opin Investig Drugs 18: 1047-1060.
39. Zheng X, Yang D, Liu X, Wang N, Li B, et al. (2010) Identification of a new anti-LPS agent, geniposide, from Gardenia jasminoides Ellis, and its ability of direct binding and neutralization of lipopolysaccharide in vitro and in vivo. Int Immunopharmacol 10: 1209-1219.
40. Nan YH, Bang JK, Shin SY, (2009) Design of novel indolicidin-derived antimicrobial peptides with enhanced cell specificity and potent anti-inflammatory activity. Peptides 30: 832-838.
41. Lichtman AH, Leung D, Shelton CC, Saghatelian A, Hardouin C, et al. (2004) Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity. J Pharmacol Exp Ther 311: 441-448.
42. Shen HC, Hammock BD, (2012) Discovery of inhibitors of soluble epoxide hydrolase: a target with multiple potential therapeutic indications. J Med Chem 55: 1789-1808.
43. Tazi el M, Essadi I, M'rabti H, Touyar A, Errihani PH, (2011) Systemic treatment and targeted therapy in patients with advanced hepatocellular carcinoma. N Am J Med Sci 3: 167-175.
44. Hoyle GW, Hoyle CI, Chen J, Chang W, Williams RW, et al. (2010) Identification of triptolide, a natural diterpenoid compound, as an inhibitor of lung inflammation. Am J Physiol Lung Cell Mol Physiol 298: L830-L836.
45. Regueiro V, Moranta D, Campos MA, Margareto J, Garmendia J, et al. (2009) Klebsiella pneumoniae increases the levels of Toll-like receptors 2 and 4 in human airway epithelial cells. Infect Immun 77: 714-724.
46. Villar J, Cabrera N, Casula M, Flores C, Valladares F, et al. (2010) Mechanical ventilation modulates Toll-like receptor signaling pathway in a sepsis-induced lung injury model. Intensive Care Med 36: 1049-1057.
47. Villar J, Cabrera NE, Casula M, Flores C, Valladares F, et al. (2010) Mechanical ventilation modulates TLR4 and IRAK-3 in a non-infectious, ventilator-induced lung injury model. Respir Res 11: 27.
48. Roger T, Froidevaux C, Le Roy D, Reymond MK, Chanson AL, et al. (2009) Protection from lethal gram-negative bacterial sepsis by targeting Toll-like receptor 4. Proc Natl Acad Sci USA 106: 2348-2352.
49. Meduri GU, Headley S, Kohler G, Stentz F, Tolley E, et al. (1995) Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 107: 1062-1073.
50. Aggarwal A, Baker CS, Evans TW, (2000) G-CSF and IL-8 but not GM-CSF correlates with severity of pulmonary neutrophilia in acute respiratory distress syndrome. Eur Respir J 15: 895-901.
51. Herrera MT, Toledo C, Valladares F, Muros M, Diaz-Flores L, et al. (2003) Positive end-expiratory pressure modulates local and systemic inflammatory responses in a sepsis-induced lung injury model. Intensive Care Med 29: 1345-1353.
52. Tremblay L, Valenza F, Ribeiro SP, Li J, Slutsky AS, (1997) Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model. J Clin Invest 99: 944-952.
53. Remick DG, Bolgos GR, Siddiqui J, Shin J, Nemzek JA, (2002) Six at six: interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 days. Shock 17: 463-467.
54. Poynter ME, Irvin CG, Janssen-Heininger YM, (2003) A prominent role for airway epithelial NF-kappa B activation in lipopolysaccharide-induced airway inflammation. J Immunol 170: 6257-6265.
55. Park GY, Christman JW, (2006) Nuclear factor kappa B is a promising therapeutic target in inflammatory lung disease. Curr Drug Targets 7: 661-668.